{"pmid":32475811,"title":"Sars-CoV-2 and black population: ACE2 as shield or blade?","text":["Sars-CoV-2 and black population: ACE2 as shield or blade?","Infect Genet Evol","Vinciguerra, Mattia","Greco, Ernesto","32475811"],"journal":"Infect Genet Evol","authors":["Vinciguerra, Mattia","Greco, Ernesto"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475811","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.meegid.2020.104361","topics":["Mechanism"],"weight":1,"_version_":1668437835047239680,"score":9.490897,"similar":[{"pmid":32405281,"pmcid":"PMC7219352","title":"Sars-CoV-2 and black population: ACE2 as shield or blade?","text":["Sars-CoV-2 and black population: ACE2 as shield or blade?","Infect Genet Evol","Vinciguerra, Mattia","Greco, Ernesto","32405281"],"journal":"Infect Genet Evol","authors":["Vinciguerra, Mattia","Greco, Ernesto"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405281","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.meegid.2020.104361","topics":["Mechanism"],"weight":1,"_version_":1666802845536485376,"score":96.649506}]}